Bioxytran (BIXT) Return on Assets [ROA] (2011 - 2026)
Bioxytran (BIXT) reported Return on Assets [ROA] of -736.59% for Q2 2026, up 1000.45 percentage points from -1737.04% a year earlier but down 290.92 percentage points from the prior quarter.
Bioxytran (BIXT) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Bioxytran posted Return on Assets [ROA] of -532.60%, up 1179.16 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of +376.00 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -1711.77% in FY2024 (+76.45 pp), -1788.21% in FY2023 (-700.34 pp), -1087.87% in FY2022 (+944.04 pp) and -2031.91% in FY2021 (-1123.31 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -3260.32% in Q1 2024 and a high of -445.66% in Q1 2026.
- Year over year, Return on Assets [ROA] has now increased in each of the last eight quarters, with an average year-over-year change of +1016.50 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2026 (a gain of 1854.49 percentage points); the low point was Q1 2024 (a drop of 2426.17 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -445.66% (Q1 2026), -521.10% (Q4 2025) and -1549.11% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | -736.59% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -736.59% |
| Mar 31, 2026 | -445.66% |
| Dec 31, 2025 | -521.10% |
| Sep 30, 2025 | -1,549.11% |
| Jun 30, 2025 | -1,737.04% |
| Mar 31, 2025 | -2,300.16% |
| Dec 31, 2024 | -1,598.92% |
| Sep 30, 2024 | -1,945.35% |
| Jun 30, 2024 | -2,780.33% |
| Mar 31, 2024 | -3,260.32% |
| Dec 31, 2023 | -2,778.59% |
| Sep 30, 2023 | -2,565.19% |
| Jun 30, 2023 | -1,771.16% |
| Mar 31, 2023 | -834.15% |
| Dec 31, 2022 | -650.78% |
| Sep 30, 2022 | -550.57% |
| Jun 30, 2022 | -465.87% |
| Mar 31, 2022 | -801.35% |
| Dec 31, 2021 | -1,027.31% |
| Sep 30, 2021 | -527.53% |
Bioxytran Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIXT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();